**Core Concept**
The question is testing the knowledge of neoadjuvant chemotherapy regimens used in the treatment of oesophageal cancer. Neoadjuvant chemotherapy refers to the administration of chemotherapy before the main treatment, which in this case is surgery. Oesophageal cancer is a type of cancer that affects the esophagus, and its treatment usually involves a combination of chemotherapy, radiation therapy, and surgery.

**Why the Correct Answer is Right**
Cisplatin is a platinum-based chemotherapy drug that is commonly used in the treatment of various cancers, including oesophageal cancer. In the context of oesophageal cancer, cisplatin is often used in combination with other chemotherapy agents, such as 5-fluorouracil (5-FU), to treat the disease. The mechanism of action of cisplatin involves the formation of platinum-DNA adducts, which interfere with DNA replication and transcription, ultimately leading to cell death. This makes cisplatin an effective agent in treating rapidly dividing cancer cells.

**Why Each Wrong Option is Incorrect**
**Option B:** Cyclophosphamide is an alkylating agent used in the treatment of various cancers, but it is not the preferred agent for neoadjuvant chemotherapy in oesophageal cancer. Cyclophosphamide works by cross-linking DNA strands, leading to DNA damage and cell death, but its use in oesophageal cancer is not as well established as cisplatin.
**Option C:** Doxorubicin is an anthracycline antibiotic that is used in the treatment of various cancers, including breast cancer and lymphoma. However, it is not commonly used in the neoadjuvant treatment of oesophageal cancer. Doxorubicin works by intercalating DNA strands, which leads to inhibition of DNA replication and transcription.
**Option D:** Methotrexate is an antifolate agent used in the treatment of various cancers, including leukemia and lymphoma. However, it is not typically used in the neoadjuvant treatment of oesophageal cancer. Methotrexate works by inhibiting dihydrofolate reductase, which is necessary for DNA synthesis.

**Clinical Pearl / High-Yield Fact**
The use of neoadjuvant chemotherapy in oesophageal cancer has been shown to improve survival rates and reduce the risk of recurrence. The most commonly used regimen for neoadjuvant chemotherapy in oesophageal cancer is the oxaliplatin-based regimen, but cisplatin-based regimens are also effective.

**✓ Correct Answer: A. Cisplatin**